Streetbeat News

Products Services

NVDA

NVIDIA has announced the release of Nemotron-4 340B, a family of open models designed to generate synthetic data for training large language models (LLMs). These models are optimized for NVIDIA NeMo and NVIDIA TensorRT-LLM, and are available for download on Hugging Face. The models aim to provide a scalable and cost-effective way to generate high-quality training data for various industries.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 4:08 pm

NVDA

Nvidia, under CEO Jensen Huang, is experiencing unprecedented market growth, with a projected market valuation of $4-$5 trillion by 2025. The company executed a 10-1 stock split and has seen a 19% increase in June, leading to a year-to-date growth of 165%. Nvidia continues to lead in AI chip technology and is making strides in quantum computing.

Portfolio Pulse from Zaheer Anwari

June 14, 2024 | 4:06 pm

URGN

UroGen Pharma shares surged after announcing positive results from its Phase 3 ENVISION trial for UGN-102, with an 82.3% 12-month duration of response and a 79.6% complete response rate at three months. Analysts subsequently raised their price targets.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 4:05 pm

FOXO

GANX

INAB

IRON

QXO

SVMH

U.S. stocks traded lower with the Dow Jones falling over 200 points. The University of Michigan consumer sentiment declined for the third consecutive month. Disc Medicine, Inc. (NASDAQ:IRON) shares rose 20% after announcing a $178 million underwritten offering. SRIVARU Holding Limited (NASDAQ:SVMH) surged 120% on news of accepting reservations for its PRANA 2.0 product. FOXO Technologies Inc. (NASDAQ:FOXO) gained 16% after entering share exchange agreements. QXO, Inc. (NASDAQ:QXO) dropped 32% following a $3.5 billion private placement. IN8bio, Inc. (NASDAQ:INAB) fell 30% after presenting Phase 1 trial data. Gain Therapeutics, Inc. (NASDAQ:GANX) declined 33% after announcing an $11 million public offering.

Portfolio Pulse from Avi Kapoor

June 14, 2024 | 4:03 pm

KYTX

Kyverna Therapeutics shares are trading lower following the release of a presentation on KYV-101, its CD19 CAR T-cell candidate.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 3:59 pm

OCUL

Ocular Therapeutix shares are trading higher following comments and updates at Thursday's Investor Day event.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 3:38 pm

AMZN

Amazon is facing a proposed class action lawsuit accusing it of monopolizing the audiobook market, leading to higher distribution fees for authors. The lawsuit claims Amazon's exclusivity agreements impair competition and affect billions in sales. The case seeks over $5 million in damages and class action status for thousands of authors.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 3:36 pm

IRON

Disc Medicine shares are trading higher following the announcement of data presentation at the European Hematology Association 2024 Congress and an underwritten offering.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 3:35 pm

AAPL

VGK

Apple is set to face charges from the European Commission for allegedly stifling competition on its App Store, marking the first use of the EU's Digital Markets Act against a Big Tech company. The charges could lead to daily penalties of up to 5% of Apple's average daily worldwide turnover. The EU is also investigating Alphabet and Meta for similar issues.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 3:34 pm

SNGX

Zacks Small-Cap Research has given Soligenix (SNGX) a $32 price valuation, emphasizing that the model is highly dependent on the continued clinical success of the company's pipeline. The valuation will be adjusted based on future clinical results.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2024 | 3:27 pm